LCLAT1 and fatty liver disease: Consequently, the targeted deletion of the ALCAT1 gene in mice not only prevented mitochondrial dysfunction, but also the development of obesity, T2DM, fatty liver disease, Parkinson’s disease, and cardiomyopathy [18,38,47,63].